Skip to main content
. 2017 Nov 22;7:16010. doi: 10.1038/s41598-017-16255-y

Table 1.

Effect of pyridoxamine on global conventional echocardiographic parameters.

Parameter Sham MI MI + PM
HR (bpm) 357 [365; 346] 365 [365; 342] 358 [388; 340]
EF (%) 67 [68; 67] 48 [60; 39]* 46 [47; 45]*
AWT (mm) 1.52 [1.55; 1.47] 0.98 [0.98; 0.93]* 1.02 [1.06; 0.98]*
PWT (mm) 1.69 [1.74; 1.61] 1.33 [1.42; 1.25]* 1.51 [1.77; 1.32]
LVEDD (mm) 6.5 [6.6; 6.4] 8.9 [9.1; 7.8]* 7.9 [8.7; 7.4]*
LVESD (mm) 4.2 [4.2; 4.1] 6.2 [6.5; 6.0]* 6.4 [6.8; 6.0]*
EDV (µL) 288 [311; 269] 570 [599; 439]* 451 [537; 384]*
ESV (µL) 94 [100; 91] 229 [266; 216]* 248 [289; 212]*
SI 0.25 [0.26; 0.25] 0.42 [0.43; 0.31]* 0.36 [0.42; 0.30]*

HR, heart rate; EF, left ventricular ejection fraction; AWT, anterior wall thickness; PWT, posterior wall thickness; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; EDV, end diastolic volume; ESV, end systolic volume; SI, sphericity index;. Data are shown as median [75th percentile, 25th percentile] in Sham (N = 5), MI (N = 5) and MI + PM (N = 6). *Denotes p < 0.05 vs Sham.